Related Experiment Video
Updated: Jul 18, 2026
High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
Identification of differentially expressed genes and regulatory relationships in Huntington's disease by
1Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.
Insights
This study used bioinformatics to analyze gene expression in Huntington's disease (HD). It identified 471 differentially expressed genes, including RNASE4, and a novel regulatory link between STAT3 and miRNA-124, offering new insights into HD pathogenesis.
Area of Science:
- Genetics
- Neuroscience
- Bioinformatics
Background:
- Huntington's disease (HD) is an inherited neurodegenerative disorder.
- The exact pathogenesis of HD remains incompletely understood.
- Gene expression alterations are implicated in HD pathophysiology.
Purpose of the Study:
- To explore the pathogenesis of Huntington's disease (HD) through computational bioinformatics analysis of gene expression.
- To identify differentially expressed genes (DEGs) and key pathways involved in HD.
- To uncover novel regulatory relationships in HD.
Main Methods:
- Downloaded and analyzed gene expression data (GSE11358) from a mutant huntingtin (HTT) knock-in cell model.
- Screened differentially expressed genes (DEGs) using the limma package in R.
- Performed functional enrichment analyses (GO, KEGG) and constructed a protein-protein interaction (PPI) network using Cytoscape and MCODE.
Main Results:
- Identified 471 DEGs, including ribonuclease A family member 4 (RNASE4).
- Discovered 41 significantly enriched KEGG pathways and key Gene Ontology terms (e.g., cytokine-cytokine receptor interaction).
- Revealed a novel regulatory relationship: signal transducer and activator of transcription 3 (STAT3) is regulated by miRNA-124 in HD.
Conclusions:
- Deregulation of 18 critical genes may contribute to the occurrence of Huntington's disease (HD).
- RNASE4, STAT3, and miRNA-124 show potential regulatory associations with HD pathological mechanisms.
- This study provides a deeper understanding of HD pathogenesis through integrated bioinformatics analysis.
Abstract:
Huntington's disease (HD) is an inherited, progressive neurodegenerative disease caused by a CAG expansion in the huntingtin (HTT) gene; various dysfunctions of biological processes in HD have been proposed. However, at present the exact pathogenesis of HD is not fully understood. The present study aimed to explore the pathogenesis of HD using a computational bioinformatics analysis of gene expression. GSE11358 was downloaded from the Gene Expression Omnibus andthe differentially expressed genes (DEGs) in the mutant HTT knock‑in cell model STHdhQ111/Q111 were predicted. DEGs between the HD and control samples were screened using the limma package in R. Functional and pathway enrichment analyses were conducted using the database for annotation, visualization and integrated discovery software. A protein‑protein interaction (PPI) network was established by the search tool for the retrieval of interacting genes and visualized by Cytoscape. Module analysis of the PPI network was performed utilizing MCODE. A total of 471 DEGs were identified, including ribonuclease A family member 4 (RNASE4). In addition, 41 significantly enriched Kyoto Encyclopedia of Genes and Genomes pathways, as well as several significant Gene Ontology terms (including cytokine‑cytokine receptor interaction and cytosolic DNA‑sensing) were identified. A total of 18 significant modules were identified from the PPI network. Furthermore, a novel transcriptional regulatory relationship was identified, namely signal transducer and activator of transcription 3 (STAT3), which is regulated by miRNA‑124 in HD. In conclusion, deregulation of 18 critical genes may contribute to the occurrence of HD. RNASE4, STAT3, and miRNA‑124 may have a regulatory association with the pathological mechanisms in HD.
